Scientists at Rutgers and other universities build technology that could lead to rapid discovery of new medicines and biomarkers hidden in genomes
Discovering the function of a gene requires cloning a DNA sequence and expressing it. Until now, this was performed on a one-gene-at-a-time basis, causing a bottleneck. Scientists at Rutgers University-New Brunswick in collaboration with Johns Hopkins University and Harvard Medical School have invented a technology to clone thousands of genes simultaneously and create massive libraries of proteins from DNA samples, potentially ushering in a new era of functional genomics.
“We think that the rapid, affordable, and high-throughput cloning of proteins and other genetic elements will greatly accelerate biological research to discover functions of molecules encoded by genomes and match the pace at which new genome sequencing data is coming out,” said Biju Parekkadan, an associate professor in the Department of Biomedical Engineering at Rutgers University-New Brunswick.
In a study published online today in the journal Nature Biomedical Engineering, the researchers showed that their technology – LASSO (long-adapter single-strand oligonucleotide) probes – can capture and clone thousands of long DNA fragments at once.
As a proof-of-concept, the researchers cloned more than 3,000 DNA fragments from E. coli bacteria, commonly used as a model organism with a catalogued genome sequence available.
“We captured about 95 percent of the gene targets we set out to capture, many of which were very large in DNA length, which has been challenging in the past,” Parekkadan said. “I think there will certainly be more improvements over time.”
They can now take a genome sequence (or many of them) and make a protein library for screening with unprecedented speed, cost-effectiveness and precision, allowing rapid discovery of potentially beneficial biomolecules from a genome.
In conducting their research, they coincidentally solved a longstanding problem in the genome sequencing field. When it comes to genetic sequencing of individual genomes, today’s gold standard is to sequence small pieces of DNA one by one and overlay them to map out the full genome code. But short reads can be hard to interpret during the overlaying process and there hasn’t been a way to sequence long fragments of DNA in a targeted and more efficient way. LASSO probes can do just this, capturing DNA targets of more than 1,000 base pairs in length where the current format captures about 100 base pairs.
The team also reported the capture and cloning of the first protein library, or suite of proteins, from a human microbiome sample. Shedding light on the human microbiome at a molecular level is a first step toward improving precision medicine efforts that affect the microbial communities that colonize our gut, skin and lungs, Parekkadan added. Precision medicine requires a deep and functional understanding, at a molecular level, of the drivers of healthy and disease-forming microbiota.
Today, the pharmaceutical industry screens synthetic chemical libraries of thousands of molecules to find one that may have a medicinal effect, said Parekkadan, who joined Rutgers’ School of Engineering in January.
“Our vision is to apply the same approach but rapidly screen non-synthetic, biological or ‘natural’ molecules cloned from human or other genomes, including those of plants, animals and microbes,” he said. “This could transform pharmaceutical drug discovery into biopharmaceutical drug discovery with much more effort.”
The next phase, which is underway, is to improve the cloning process, build libraries and discover therapeutic proteins found in our genomes, Parekkadan said.
The Latest on: Precision medicine
- Leukemia Protein Atlas Holds Power to Accelerate Precision Medicine on April 17, 2019 at 7:15 am
Statistics can be a great tool for analyzing datasets and it can also be a sobering means to provide a stark reality. For instance, recent data suggests that approximately every three minutes one ... […]
- The Latin America precision medicine market is expected to expand at a CAGR of 9.35% leading to a revenue of USD 6.48 Bn by 2023 on April 17, 2019 at 6:22 am
Precision medicine is a combination of molecular biology techniques and system biology. Big data analytics is expected to drive the market in Latin America. Latin American countries like Brazil, ... […]
- Can precision medicine keep Singapore ahead in advanced care? on April 16, 2019 at 11:02 pm
However, now the medical community is quickly realising that cancer is far more complex than a single disease. For example, even if a tumour is in the same location for two patients, the genetic ... […]
- Sutter Health, UPMC team up on precision medicine to improve multiple sclerosis treatments on April 16, 2019 at 11:48 am
Sutter Health is teaming up with the University of Pittsburgh Medical Center and biomedical informatics and data management company DNAnexus on precision medicine research to develop more personalized ... […]
- U of T launches PRiME, a precision medicine initiative on April 16, 2019 at 9:40 am
“The idea is to bring together the cutting-edge work we are doing in precision medicine and give it a central focus point and vision," said Shana Kelley of U of T’s Leslie Dan Faculty of Pharmacy ... […]
- Collecting health data for ‘precision medicine’ of the future on April 15, 2019 at 7:18 am
ST. LOUIS – Dr. Joan Davis from the Missouri School of Dentistry and Oral Health joins us to promote the "All of Us" research program's health data collection. The organization is sending their ... […]
- A Mathematical Representation of Precision Medicine on April 12, 2019 at 12:00 pm
Diseases most often arise from a confluence of genetic and environmental factors. Precision medicine promises the ability to understand and treat disease in an individualized manner. To fully enable ... […]
- Viewpoint: DNA data ‘rat race’ bringing down costs of precision medicine but perils of security risks escalate on April 12, 2019 at 9:44 am
It is said that this is the best of times for direct to consumer (DTC) genetic testing companies, human disease genomics, and the launch of genomic data marketplaces. As a result, the rise of ... […]
- Precision Therapeutics’ Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative on April 11, 2019 at 6:02 am
Precision Therapeutics' Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine Opportunities for Cancer Patients Helomics to provide CRO services and its ... […]
- New cancer drug targets accelerate path to precision medicine on April 10, 2019 at 10:02 am
In one of the largest studies of its kind, researchers used CRISPR technology to disrupt every gene in over 300 cancer models from 30 cancer types and discover thousands of key genes essential for ... […]
via Google News and Bing News